Approximately 2% of the human genome consists of protein-coding regions. Therefore, the majority of transcripts are noncoding RNAs, such as microRNA (miRNA) and long noncoding RNAs (lncRNAs). In ischemic heart disease, the majority of miRNAs are repressors or destabilizers of target messenger RNAs. The lncRNAs are a second class of noncoding RNAs that have recently gained attention for their roles in heart disease and in regulating the functions of miRNA. In this review, we summarize the role of miRNA in pathological cardiac hypertrophy and myocardial infarction. In addition, we discuss the functional interactions of miRNA and lncRNA and its impact on these ischemic heart diseases.
CarninciPKasukawaTKatayamaS; RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group). The transcriptional landscape of the mammalian genome. Science. 2005;309(5740):1559–1563.
2.
ENCODE Project Consortium; BirneyEStamatoyannopoulosJADuttaA. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447(7146):799–816.
3.
ChengJKapranovPDrenkowJ. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 2005;308(5725):1149–1154.
4.
ClarkMBChoudharyASmithMA. The dark matter rises: the expanding world of regulatory RNAs. Essays Biochem. 2013;54:1–16.
5.
JacquierA. The complex eukaryotic transcriptome: unexpected pervasive transcription and novel small RNAs. Nat Rev Genet. 2009;10(12):833–844.
6.
KimVNHanJSiomiMC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10(2):126–139.
7.
GhildiyalMZamorePD. Small silencing RNAs: an expanding universe. Nat Rev Genet. 2009;10(2):94–108.
8.
GeislerSCollerJ. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Bio. 2013;14(11):699–712.
9.
HirakataSSiomiMC. piRNA biogenesis in the germline: from transcription of piRNA genomic sources to piRNA maturation. Biochim Biophys Acta. 2016;1859(1):82–92.
10.
PasquinelliAE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13(4):271–282.
11.
KimDHSaetromPSnoveORossiJJ. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A. 2008;105(42):16230–16235.
12.
FilipowiczWBhattacharyyaSNSonenbergN. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nat Rev Genet. 2008;9(2):102–114.
13.
SelbachMSchwanhausserBThierfelderNFangZKhaninRRajewskyN. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58–63.
14.
LeeRCFeinbaumRLAmbrosV. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–854.
15.
WightmanBHaIRuvkunG. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern-formation in C. elegans. Cell. 1993;75(5):855–862.
16.
MoranVAPereraRJKhalilAM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012;40(14):6391–6400.
17.
WapinskiOChangHY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(10):354–361.
18.
CastelSEMartienssenRA. RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond. Nat Rev Genet. 2013;14(2):100–112.
HunterJJChienKR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999;341(17):1276–1283.
21.
Wikman-CoffeltJParmleyWWMasonDT. The cardiac hypertrophy process. Analyses of factors determining pathological vs physiological development. Circ Res. 1979;45(6):697–707.
22.
van RooijESutherlandLBQiXXRichardsonJAHillJOlsonEN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science. 2007;316(5824):575–579.
IkedaSHeAKongSW. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol. 2009;29(8):2193–2204.
26.
LiuFLiNLongB. Cardiac hypertrophy is negatively regulated by miR-541. Cell Death Dis. 2014;5:e1171.
27.
MontgomeryRLHullingerTGSemusHM. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation. 2011;124(14):1537–1547.
28.
van RooijESutherlandLBLiuN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006;103(48):18255–18260.
29.
WangKLinZQLongB. Cardiac hypertrophy is positively regulated by microRNA miR-23a. J Biol Chem. 2012;287(1):589–599.
30.
LiNWangKLiPF. MicroRNA-34 family and its role in cardiovascular disease. Crit Rev Eukaryot Gene Expr. 2015;25(4):293–297.
31.
van RooijESutherlandLBThatcherJE. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A. 2008;105(35):13027–13032.
32.
ThumTGrossCFiedlerJ. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456(7224):980–984.
33.
LiangHZhangCBanT. A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis. Int J Biochem Cell Biol. 2012;44(12):2152–2160.
34.
RoySKhannaSHussainSR. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 2009;82(1):21–29.
WangKZhouLYWangJX. E2F1-dependent miR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1. Nat Commun. 2015;6:7619.
40.
WangKLiuCYZhangXJ. miR-361-regulated prohibitin inhibits mitochondrial fission and apoptosis and protects heart from ischemia injury. Cell Death Differ. 2015;22(6):1058–1068.
41.
WangKAnTZhouLY. E2F1-regulated miR-30b suppresses Cyclophilin D and protects heart from ischemia/reperfusion injury and necrotic cell death. Cell Death Differ. 2015;22(5):743–754.
42.
PennanenCParraVLópez-CrisostoC. Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway. J Cell Sci. 2014;127(pt 12):2659–2671.
43.
UchidaSDimmelerS. Long noncoding RNAs in cardiovascular diseases. Circ Res. 2015;116(4):737–750.
44.
OunzainSBurdetFIbbersonMPedrazziniT. Discovery and functional characterization of cardiovascular long noncoding RNAs. J Mol Cell Cardiol. 2015;89(pt A):17–26.
45.
SchonrockNHarveyRPMattickJS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res. 2012;111(10):1349–1362.
46.
HanPLiWLinCH. A long noncoding RNA protects the heart from pathological hypertrophy. Nature. 2014;514(7520):102–106.
47.
SongCZhangJLiuY. Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy. Oncotarget. 2016;7(10):10827–10840.
48.
WangJXGaoJDingSL. Oxidative modification of miR-184 enables it to target Bcl-xL and Bcl-w. Mol Cell. 2015;59(1):50–61.
49.
GiannakakisAZhangJJenjaroenpunP. Contrasting expression patterns of coding and noncoding parts of the human genome upon oxidative stress. Sci Rep. 2015;5:9737.
50.
YoonJHAbdelmohsenKGorospeM. Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol. 2014;34:9–14.
51.
WangKLiuCYZhouLY. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015;6:6779.
52.
WangKLongBZhouLY. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun. 2014;5:3596.
53.
WangKSunTLiN. MDRL lncRNA regulates the processing of miR-484 primary transcript by targeting miR-361. PLoS Genet. 2014;10(7):e1004467.
54.
WangKLiuFZhouLY. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res. 2014;114(9):1377–1388.
55.
WangJXZhangXJLiQ. MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD. Circ Res. 2015;117(4):352–363.
56.
NelsonBRMakarewichCAAndersonDM. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science. 2016;351(6270):271–275.
